Cannabis users experience increased cortical activation during the brain’s resting state when compared with nonusers which may impair brain activity and disrupt cognitive processes.
A new system is being introduced to allow black and gray market cannabis producers to introduce and protect their unique cannabis strains in the Canadian cannabis market.
The authors behind the work believe that CBD may constitute an excellent candidate for the treatment of MS and other autoimmune diseases as a novel, non-psychoactive therapeutic.
This article highlights the areas where Illinois could make improvements in order to establish a more efficient and effective medicinal cannabis treatment program.
Self-reporting study fuels debate over the potential risks to mental health of long term, high THC concentrate use.
A clinical trial involving 20 Canadian children with severe intractable epilepsy has posted resulting indicating cannabis oil could reduce seizures by over 70%.
By analyzing the THC content of a saliva sample, researchers have found that it is possible to accurately determine if someone has used cannabis via smoking, vaporization or ingestion of edibles, within the past 24 hours.